The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.
For select patients with advanced heart failure (AHF), durable left ventricular assist device (LVAD) therapy can be a life-sustaining option that improves quality of life. Since its introduction a few ...
When it comes to fixing dodgy tickers, memorable breakthroughs include the world’s first heart transplant (South Africa’s Dr Christiaan Barnard in 1967), the first artificial heart bridging job (Texas ...
The MarketWatch News Department was not involved in the creation of this content. -- Peer-reviewed data published in Neurosurgery show that SOLOPASS(R) 2.0 delivers significantly higher accuracy than ...
98% of placements using SOLOPASS® 2.0 entered the ventricular system, versus only 10% of freehand placements. 86% of placements using SOLOPASS® 2.0 accurately reached the ipsilateral frontal horn ...
Former Vice President Dick Cheney, who died Monday night, was a testament to the power of modern cardiology, a live demonstration of the ways that new devices and surgical techniques — many of them ...
Background/aim Frequent premature ventricular complexes (PVCs) have historically been regarded as benign in structurally normal hearts, yet emerging evidence suggests substantial cardiovascular risk.
OAK RIDGE, TN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces significant commercial momentum and ...
Three Studies Validate BVA-Guided Care Significantly Cuts Hospital Readmissions and Boosts Survival in High-Cost Heart Failure Segments OAK RIDGE, TN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Daxor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback